Attempts to focus on isolating metabolic differences between IDH mutant and IDH wildtype glioblastomas have historically suffered from an unproven assumption that the metabolic differences between IDH mutant and IDH wildtype tumors can be largely attributed to the presence or absence of the IDH mutation itself [12, 13]. This evidence concerns the gene IDH1 and glioblastoma.